Public Company News

Stargroup’s quest for total market domination in Australia received a shot in the arm this week after the company announced yet another acquisition of a rival ATM machine operator taking their total number of ATM machines around Australia to over 500 units. The acquisition of Fast Cash for $4.2m will take Stargroup’s projected FY 18 EBITDA from $4.7m to $5.7m.

Neometals’ dream of capturing value all along the lithium battery supply chain is one step closer following great test results for an exciting new type of battery material that can potentially replace graphite. Batteries using the new anode material known as Lithium Titanate outperformed commercially available rivals in recent tests conducted by the company. 

Peppermint Innovation have launched a game changing trial of their technology in the Philippines that promises to revolutionize the way millions of Filipinos pay their household bills and transfer money to friends and family. The trial, which received the green light from the country’s central bank, is an innovative solution for the 70% of Filipinos who don’t operate a bank account.

Peppermint Innovation are gaining traction for their bill payment and money transfer APP with millions of Filipino’s who don’t operate a bank account. The Perth company has signed a second major distribution partner who will resell their platform via a 14,000 strong agent network. Peppermint also recently won a Fintech Award for “Excellence in Financial Inclusion.”

Lithium Australia’s innovative "Sileach" Lithium processing technology has played a crucial role in securing a joint venture in Germany that plans to extract lithium from mica for the huge European market. The German partner in the new joint venture locked in the deal after exhaustive due diligence showed Sileach was ideal for extracting lithium from their tin deposits in Europe.

When it comes to saving the lives of beach goers, there are few bigger names around the world than Bondi Rescue’s Bruce “Hoppo” Hopkins. The chief lifeguard at Bondi Beach has teamed up with WA-based Shark Mitigation Systems to promote their innovative shark detecting "Clever Buoy" technology. Hopkins first trialed the technology at Bondi in 2016.

Lithium Australia’s processing expertise has produced exceptional results from metallurgical testing of the Agua Fria Lithium clay prospect in Mexico, extracting up to 99% Lithium without roasting in just four hours. The result is a major boost for the economics of Agua Fria which is adjacent to the world’s largest known Lithium clay deposit.

Blina Minerals have moved quickly at their new Dingo Gold project in the Eastern Goldfields, with detailed geological mapping and a geochemical survey underway just a fortnight after taking control. Dingo has shallow and deeper gold targets that have not been properly drill tested and offers up significant upside on Blina’s bargain acquisition price of just $20,000.

Analytica have appointed a global heavyweight in the pharmaceutical industry to its board of directors as they gear up for the international launch of an innovative medical device that combats urinary incontinence. Dr Peter B. Corr, the former head of R&D at Pfizer, has joined the Analytica board, strengthening ties he already has as a significant shareholder.

An independent clinical trial of MGC Pharma’s cannabis-based dermatological creams has produced spectacular results with the trials showing an 80% improvement in acne prone skin, 73% improvement in psoriatic plaques, 86% improvement of irritated skin and over 70% improvement in the visual appearance of redness, dryness, flaky and oily skin conditions.

Blackham’s latest round of drilling at Wiluna has produced a best-ever result of 15.4 metres at more than 21 g/t gold, located in a new high-grade shoot that is outside the existing open-pit mine plan. The new drill results revealed much more mineralisation around the old West Pit and make a ‘super pit’ stretching up to 2km a real possibility.

PharmAust’s trials of its promising anti-cancer drug in dogs have produced encouraging early results, reducing the size of tumours in three out of four dogs with no other treatment. The early-stage trials have also shown it will be safe to give dogs significantly higher doses, which could lead to some spectacular results in the next stage of trials.